HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan

This article was originally published in The Rose Sheet

Executive Summary

Fragrances and flavors supplier stock closed at approximately $312.50 (510 CHF) on its first day of trading on the Swiss Market Index June 8. Givaudan Roure's former parent company, Roche, voted to spin off the company at its May 9 general assembly; each Roche stockholder will receive one share of GIVN. Roche announced the $3.41 bil. transaction in December (1"The Rose Sheet" Dec. 13, 1999, p. 6). The new company, which will be renamed Givaudan, will continue to be headed by CEO Jurg Witmer. Givaudan generated $1.37 bil. in sales in 1999 and estimates it holds 14% of the worldwide flavors and fragrances market

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel